A bipartisan group of legislators introduced a new bill in the House of Representatives, titled the PBM Reform Act (H.R. 4317), that includes all the NCPA legislative priorities that were in the original Continuing Resolution package from December 2024. This bill comes after the Senate parliamentarian ruled that PBM reform provisions couldn’t be included in the June budget reconciliation negotiations.
In a statement, NCPA CEO Douglas Hoey said, “As PBMs continue manipulating drug pricing, extinguishing their competition, and raking in massive profits, patients and pharmacies are suffering. We need help, and we need it quickly. Systemic changes like those in the PBM Reform Act must pass and be enacted as soon as possible. We’re grateful for this bill’s introduction and will do everything we can to push it across the finish line.”
The legislation was introduced by Reps. Buddy Carter (R-Ga.), Debbie Dingell (D-Mich.), Greg Murphy (R-N.C.), Deborah Ross (D-N.C.), Jodey Arrington (R-Texas), Diana Harshbarger (R-Tenn.), Vicente Gonzalez (D-Texas), Rick Allen (R-Ga.), Raja Krishnamoorthi (D-Ill.), John Rose (R-Tenn.), Derek Tran (D-Calif.), and Nicole Malliotakis (R-N.Y.). You can read Carter’s press release here and the full text here.
